The Saccharomyces cerevisiae MCM1 gene product is a protein with multiple functions. It is a transcription factor necessary for expression of mating-type-specific genes and is also required for the maintenance of minichromosomes. MCM1 shows DNA-binding specificities similar to those of two previously reported DNAbinding factors, pheromone/receptor transcription factor (PRTF) and general regulator of mating type (GRM)~ like PRTF, its activity can be modulated by the al protein. MCM1 binds to the dyad symmetry element 5'-CCTAATTAGG and related sequences, which we refer to as MCM1 _control _elements (MCEs). MCEs are found within the regulatory regions of a-and ,,-specific genes. Direct and indirect DNA binding assays suggest that a conserved 5'-ATTAGG in one-half of the dyad symmetry element is important for MCM1 binding whereas variants in the other half are tolerated. We have used a novel DNase I 'nicking interference' assay to investigate the interaction of MCM1 with its substrate. These data suggest that MCM1 binds as a dimer, interacting symmetrically with the ATTAGG residues in each half of the binding site. MCM1 contains striking homology to the DNA-binding domain of the human serum response factor (SRF) which mediates the transient transcriptional activation of growth-stimulated genes by binding to the serum response element (SRE). We have shown that MCM1 binds to the human c-fos SRE in vitro and, like other MCEs, the c-fos SRE exhibits MCM1-mediated upstream activating sequence (UAS) activity in vivo.
Autonomously replicating sequences (ARSs) are believed to be in vivo origins of replication on plasmids (Brewer and Fangman 1987; Huberman et al. 1987 ) and on yeast chromosomes (Saffer and Miller 1986) . One approach for identifying gene products that may be involved in the initiation of DNA synthesis in Saccharomyces cerevisiae is to isolate mutants that affect the function of ARSs (Maine et al. 1984; Gibson et al. 1986 ). Previously, we have isolated such mutants, which are known as mcm for their defect in the maintenance of minichromosomes. Some of these mutants affect the stability of minichromosomes carrying only certain ARSs but not others, suggesting that not all ARSs are regulated similarly (Maine et al. 1984) . Recently, we have reported the analysis of the mutant mcml-1, which was identified originally as an ARS-specific, minichromosome maintenance-defective mutant. It shows a mating defect in a cells that is due to reduced transcription of MFal and STE3, two genes required for the mating of a cells. These results suggest that MCM 1 acts as a transcriptional activator of a-specific genes (Passmore et al. 1988) .
Cell type in yeast is determined by the mating type [MAT) locus. The MATa allele encodes two proteins, al and a2, which affect the expression of cell-type-specific genes. Genetic and biochemical analyses suggest that the al protein is a positive regulator for the transcription of a-specific genes (Sprague et al. 1983; Fields and Herskowitz 1985} and the a2 protein is a negative regulator for the transcription of a-specific genes (Wilson and Herkowitz 1984; Hartig et al. 1986) . Because the overproduction of MCM1 can complement a matal mutation partially, yet expression of MCM1 is independent of the MAT allele [Passmore et al. 1988) , it is possible that MCM1 may interact with the al protein to activate the transcription of a-specific genes. In contrast, a cells containing the metal-1 mutation show only a twofold reduction in mating efficiency and a similar reduction in the transcript levels of a-specific genes. The modest effect of mcml-I mutation on the expression of a-specific genes may reflect a limited role of MCM1 in the activation of a-specific genes. Although genetic evidence indicates that the al protein is a transcriptional activator of a-specific genes, there has been no demonstration of any direct interaction of al with DNA from the upstream regions of a-specific genes. In searching for a cofactor of the (xl protein, Bender and Sprague (1987) identified a DNAbinding activity in yeast extracts called the pheromone/receptor transcription factor (PRTF), which binds to the upstream region of (x-specific genes but only in the presence of the c~l protein. In contrast, PRTF can bind to a-specific genes in the absence of (xl. At the same time, Keleher et al. (1988) identified a DNA-binding factor general regulator of mating (GRM), which binds cooperatively with the (x2 protein to operator sites of aspecific genes. Mutations in the GRM-binding sites within synthetic operators result in the derepression of downstream reporter genes, suggesting that GRM acts as a corepressor with the (x2 protein. Interestingly, the activities of PRTF and GRM are found in all cell types and the sequence motif recognized by PRTF is similar to that recognized by GRM, which suggests that these two factors may, in fact, be the same. It was proposed that PRTF/GRM acts both as a coactivator with (xl in the regulation of (x-specific genes and a corepressor with (x2 in the repression of a-specific genes in (x cells (Bender and Sprague 1987; Keleher et al. 1988) .
The phenotypes of the mcml-1 mutant are consistent with those expected of a mutant defective in PRTF/ GRM except that derepression of a-specific genes was not observed in (x cells containing the rncml-1 mutation (Passmore et al. 1988) . To investigate the relationship between MCM1 and PRTF/GRM, as well as the possibility that MCM1 may bind to ARSs in its role in plasmid maintenance, it was of interest to carry out a detailed analysis of the binding speficities of MCM1. In this paper we present evidence suggesting that MCM1 acts directly as a transcriptional activator of cell-typespecific genes. We have shown that the amino-terminal 188-amino-acid portion of the MCM1 protein expressed and purified from Escherichia coli binds to the upstream regulatory elements of a and (x-specific genes. DNase I protection experiments indicate that the DNA-binding specificity of MCM 1 is very similar to that of PRTF and GRM.
MCM1 is an essential gene that is expressed in all cell types (Passmore et al. 1988) . It encodes a protein of 286 amino acids containing striking homology to the human serum response factor (SRF) (Norman et al. 1988 ) and another yeast regulatory protein, encoded by ARG80 (Dubois et al. 1987) , located 700 bp upstream of MCM1 (Passmore et al. 1988) . Further analysis of the binding specificity of MCM1 reveals that it will bind to a 14-bp element called the serum response element (SRE) (Treisman 1986) , which is used by higher cells to control genes in response to growth factors. This response is mediated through the action of SRF, which binds to the SRE. We show that the human c-los SRE inserted in front of a reporter gene serves as an upstream activating sequence (UAS), which is responsive to the level of MCM1 in yeast. Thus, it appears that these two homologous transcription factors, MCM1 and SRF, of fungal and mammalian origins, respectively, recognize a conserved DNA element. Possible analogous functions served by these two transcription factors in their respective systems are discussed.
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Results
The MCM1 gene product is necessary for the efficient transcription of certain cell-type-specific genes and is also required for growth. MCM1 encodes a protein of 286 amino acids containing an unusually acidic region in which 19 of 20 residues are glutamic acid or aspartic acid. Polyanionic regions are characteristic of transcription activators (Hope and Struhl 1986; Keegan et al. 1986) , suggesting that MCM1 may act to effect transcription by presenting this domain to the transcription machinery. We have begun a biochemical analysis of the MCM1 protein to determine whether the MCM1 protein mediates its effect on transcription directly by binding DNA-regulatory elements. We have overproduced and purified from E. coli a fusion protein containing the amino-terminal 188-amino-acid portion of the MCM1 protein. This region of the protein has been shown in vivo to contain all of the functions necessary for transcription of a-specific genes, minichromosome maintenance, and viability (Passmore et al. 1988 ).
Overproduction of a hybrid 4)-10-MCM1 protein
A chimeric gene that contains a 575-bp BamHI-EcoRI fragment encoding the amino terminus of the MCM1 protein was fused in-flame to the gene encoding the phage T7 4)-10 coat protein borne on the plasmid pETMCM1 (1-188) (Fig. 1A) . The amino terminus of this fusion protein contains 13 amino acids from the 4)-10 protein followed by 6 amino acids coded for by the region just upstream of the MCM1 open reading frame (ORF) and then 188 amino acids of the MCM1 protein {Fig. 1B). The 4)-10-truncated MCM1 fusion protein [MCM1 (1-1881] was overexpressed in an E. coli strain harboring pETMCM1 (1-188). Lysates were prepared and fractionated as described in Experimental procedures. The MCM1 (1-188) used for the DNA-binding studies is shown in the left panel of Figure 1C . On the basis of Coomassie blue staining of the gel, we estimate that at least 30% of this protein preparation is MCM1 (1-188). The right panel of Figure 1C shows a Western blot of the purified protein developed with a polyclonal anti-MCM1 antibody. The MCM1 (1-188) truncated protein has an apparent molecular weight of about 29 kD, which is higher than its expected molecular weight of 21 kiD, presumably due to its polyacidic tract (Earnshaw et al. 1987) . In fact, the full-length protein also has an anomalous apparent molecular weight of 42 kD {data not shown). The second band apparent in the Western blot is a proteolytic fragment of MCM1 (1-188) and accounts for -10% of the total immuno-cross-reactive material.
MCM1 binds to the UASs of MFal
Because mutations in MCM1 can lead to a decrease in transcription of the MF(Xl gene, we examined the ability of the MCM1 protein to interact with the regulatory region of this gene using a DNase I protection assay. Endlabeled MFal DNA from the 5'-upstream region was digested partially with pancreatic DNase I in the presence of varying amounts of the purified MCM1 (1-188) (Fig.  2) . The three regions of the promoter protected from DNase I digestion by MCM1 (1-188) are shown. Each footprinted region contains a sequence motif related to the 10-bp dyad symmetry element CCTAATTAGG. Two of these regions correspond to MF~I UAS2 (proximal UAS) and UAS1 (distal UAS), the two MF~I UASs that require ~ 1 protein for activity, and are silent in diploid cells (Inokuchi et al. 1987) .
The sequence of the footprinted region nearest the MF~I mRNA start site is shown in Figure 2 . The footprint of the coding strand covers -30 bp, with the most strongly protected region near the center (solid bar). This region corresponds to the 10-bp dyad symmetry element CCTAATTAGG. The protected region extends beyond the symmetry element -10 bp on either side (stippled bars), and is punctuated by DNase I-sensitive sites. MCMl-induced DNase I-sensitive sites also are observed within and between the footprinted regions (arrowheads in Fig. 2) . The position and extent of the footprints that result from the binding of MCM1 (1-188) to the UASs of MF~I are similar to those footprinted by PRTF in the presence of etl (Bender and Sprague 1987) . Although Bender and Sprague showed that the PRTF activity in cell extracts requires the a 1 protein for binding to the MF~I UAS, we have shown here that MCM1
(1-188) purified from E. coli binds to this substrate without the aid of any additional yeast proteins. Bender and Sprague suggested that the large region footprinted by PRTF in the presence of od was due to the simultaneous binding of PRTF and al to the MFe~I UASs, interacting with sites P and Q, respectively. However, we have shown that MCM1 alone footprints the central region of the P site, the MCM1 control element (MCE), as well as a portion of the Q site. The difference in their requirements for otl may be due to the choice of carrier DNA used in these experiments.
MCM1 binds to the upstream-regulatory sequences of both a-and R-specific genes Sequences similar to the dyad symmetry elements present upstream of the MF~I coding region are also found within the operators of the a-specific genes, STE2 and STE6 (Fig. 3B ). To determine whether MCM1 (1-188) is capable of binding both a-and e~-specific UASs, we used a gel retardation assay to monitor its binding. This assay was tested first on the natural sequences of the MFal promoter. When MCM1 (1-188) and labeled (Fig. 3A) . Both UAS elements formed complexes with MCM 1 (1-188), and in each case we saw multiple retarded bands. The STE2 promoter also was able to form complexes with MCM1 (1-188), giving a similar pattern of multiple bands (Fig. 3A) . Oligonucleotides corresponding to the dyad symmetry element (DSE~4), or the related 'core' element found within the STE6 promoter (STE6-o), were cloned into a polylinker site on a plasmid (sequences of the oligonucleotides are shown in Experimental procedures). The vector DNA without the oligonucleotide insert did not serve as a substrate for MCM1 (1-188) (Fig.   3A, lanes 1 and 2) . However, when DNA fragments containing DSE~4 or STE6-o were used in these assays, we found that they were good substrates for MCM1 (1-188) (Fig. 3A, lanes 10 and 12) , indicating that the DSE14 or STE6-o elements were sufficient for binding.
The interaction of MCM1 with the regulatory region of the STE2 gene was localized by footprinting analysis (data not shown). MCM1 was found to footprint the region of the STE2 operator that contains MCE, the sequence motif related to the MCMl-binding site found upstream of MF~I. We noted that the interaction of MCM1 with the STE2 operator is similar to that of GRM with the STE6 operator (Keleher et al. 1988; Sauer et al. 1988) .
~1 enhances binding of MCM1
If MCM1 is in fact the same as PRTF, then its binding to the UASs of a-specific genes should be enhanced by the 1 protein. We have shown previously that overexpression of the MCM1 protein in a mat~l mutant can suppress the mating defect of this strain partially, suggesting that MCM1 and the al protein may interact with each other (Passmore et al. 1988) . A direct demonstration that oil enhances the binding of MCM1 is shown by the titration of MCM1 (1-188) against a fixed concentration of DNA substrate, in the presence or absence of otl protein. At a concentration of MCM1 (1-188) where binding to its substrate is no longer observable, addition of partially purified otl protein expressed in E. coli (a kind gift from E. Grayhack) was found to enhance the binding of MCM1 to UAS2 of MF~I. This can be seen by comparing the amount of shifted material in the PAGE-retardation assay shown in Figure 4A , lanes 4 and 5. Both lanes contain the same amount of MCM1, but lane 5 contains in addition oL1 protein in an approximately equal molar amount.
To verify that MCM1 was responsible for the formation of the slowly migrating protein-DNA complexes observed in the gel-retardation assays described above, MCMl-specific antiserum was added to several control reactions. The MCM1 protein could be detected in the retarded complex whether in the presence or absence of the al protein, as shown by the formation of a ternary a n t i b o d y -M C M 1 -D N A complex (Fig. 4A , lanes 7 and 8). This complex is observed when antibody specific to MCM1 is used, but not with the preimmune serum (Fig.  4A , bottom panel). We do not see any change in the mig-ration of the retarded bands in the presence of the a l protein (Fig. 4 , cf. lanes 7 and 8), nor do we see an etl-DNA complex in the absence of the MCM1 protein (Fig.  4 , lane 6).
To examine more closely the effect of a l on the interaction of MCM1 with MFcH-UAS2, we used a DNase I-footprinting assay. The results of such an experiment using a synthetic oligonucleotide (MFedp60) containing MFc~I-UAS2 are shown in Figure 4B . As might have been expected from the failure of the oL1 protein to form a complex detectable using the gel-retardation assay, the or1 protein alone did not yield a footprint on the MFal- UAS2 sequence (Fig. 4B , lane C). However, the binding of MCM1 to MFaI-UAS2 was enhanced by the presence of al, as revealed by a decrease in the intensity of the bands throughout the footprinted region and an extension of the footprint by about 4 bp in the Q region (Fig.  4B , cf. lanes C and D, lanes E and F), the proposed site of action of al (Bender and Sprague 1987) . Similar effects were observed when the EcoRI-BamHI fragment containing the natural MFal upstream sequence from pKSMFal was examined (data not shown). These results may be due to a more complete occupancy by MCM1 in the presence of al or due to a different DNA-protein complex formed by the simultaneous binding of MCM 1 and al. To distinguish between these possibilities, we examined the MCMl-dependent DNase I protection pattern of gel-purified M C M 1 -M F~I -U A S 2 complexes (C1 and C2) that had been separated on a polyacrylamide gel after treatment with DNase I. The pattern of DNase I protection from these gel-purified complexes should represent the maximum possible occupancy by MCM1 alone. The DNase I protection pattern from these complexes was determined by densitometric tracing (data not shown) and found to be the same as that afforded by MCM1 alone in solution (cf. Fig. 4C , lanes C1 and C2 with Fig. 4B , lanes B and E). Thus, it appears that the presence of al results in both an increase in the occupancy by MCM1 and the formation of a complex that interacts with an extended region of the MFa 1 promoter that now spans all of the Q site as well as the P site. These results suggest that MGM1 and al bind cooperatively to the UASs of a-specific genes. In addition, the isolated complexes C~ and C2 had indistinguishable DNase I protection patterns for both the coding strand and the noncoding strand ( Fig. 4C) suggesting that MCM1 interacts with the DNA in the different complexes in a similar manner.
MCM1 binding site specificity
To examine the DNA-binding specificity of the MCM1 protein in more detail, we used a number of variant dyad symmetry elements in a competition assay to determine the relative affinity of MCM1 (1-188)for its substrates ( Fig. 51 . As competitor DNA, oligonucleotides corresponding to the MCEs of MFal (UAS1) and STE2 were synthesized. In addition, oligonucleotides corresponding to variants of the dyad symmetry element that contain symmetric double mutations were synthesized and polymerized. These variants have either altered end-to-end spacing (+ 2 and -2) that changes half of the MCE, or altered internal AT sequences, but all exhibit dyad symmetry (Fig. 5B) . A polymer of the oligonucleotide CCTAATTT, which contains only the first 7 bp of the MCE, was also included in these studies.
Cold competitor DNA was added to a reaction mix followed by MCM1 {1-188) and a labeled HindIII fragment containing the STE2 UAS. The reaction mixture was separated by PAGE. The ability of an oligonucleotide to compete was indicated by the amount of unbound labeled STE2 UAS (Fig. 5A ). The affinity of MCM1 (1-188)for these different MCE-like sequences in decreasing order w a s : DSE14 > CCTAAT, MFad-o, STE2-o > T3A, A4T, A5T > + 2, -2. These results indicate that the actual sequence of the 6 ATs in the middle Bender and Sprague (1987) . (C} DNase I protection pattern of MCM1/MFal-UAS2 complexes. MFotlp60 was labeled on either the coding or the noncoding strand. Labeled MFcxl and MCM1 were incubated and then digested with DNase I. MFalp60/MCM1 complexes were isolated using the gel-retardation system. {Lanes M) Maxam-Gilbert G + A sequence ladders; (lanes F) DNA digested in the absence of MCM1 protein; (lanes C1) the more abundant, intermediate mobility complex; (lanes C2) the more slowly migrating complex. strongly affects the binding affinity of MCM1. We noticed that all of the natural binding sites have on the left side of the MCE one copy of the sequence CCTAAT while deviations occur in the right half. Furthermore, the CCTAAT polymer (CCTAATTT)~ competed very well for the binding of MCM1 (1-188) in these assays. This half-site effect is often seen in the case of dyad symmetry elements. We propose, based on these direct and indirect binding data, that the optimum site for the binding of MCM1 (1-188) is the perfect dyad symmetry element CCTAATTAGG.
Interaction of MCM1 with its binding site
We have used the nicks introduced by DNase I as the basis for a DNA-binding interference assay (nicking interference). DNase I in the presence of Mg 2+ and Ca 2+ introduces single-stranded nicks in double-stranded DNA. The phosphodiester bond is hydrolyzed, producing 5' phosphate and 3' hydroxyl groups. Because the region of the MFal promoter that can be footprinted by MCM1 can be cleaved at almost every base by DNase I, we decided to make use of nicks introduced by DNase I in a binding-interference assay.
A synthetic oligonucleotide containing UAS2 (MFetlp60) from the promoter of MFetl was end-labeled and then nicked with DNase I. This collection of nicked D N A was incubated with excess MCM1 protein and allowed to bind. To identify the nicks that interfere with binding, the bound and unbound fractions were separated using the gel-retardation system and then examined on a sequencing gel (Fig. 6) . Nicks that interfere with binding would be expected to be depleted from the bound fractions and enriched in the nonbound fractions. Within the limits of this method, namely the nonrandom cutting by DNase I, the pattern of nicking inhibition appeared symmetrical. Nicks introduced in the MCE 5' to Ts, A4, As, T6, T7, As, Gg, Glo, o r Ell were found to reduce binding of MCM1. Furthermore, nicks introduced 5' to As, W6, As, G9, or G10 abolished binding.
Results of DMS-interference assays are consistent with those of nicking interference assays, indicating that MCM1 interacts with G 9 and G~o on both strands in the
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Cold Spring Harbor Laboratory Press on November 6, 2017 -Published by genesdev.cshlp.org Downloaded from major groove and that these contacts are essential for binding (Fig. 6 , only noncoding strand is shown). Because these symmetric nicks can eliminate binding, MCM1 probably interacts with its symmetric binding site as a dimer, contacting ATTAGG on both strands. The localized nature of the nicks that eliminate binding argues against any major structural change. We cannot determine from these results whether the residues identified as important are involved in phosphate-or basespecific interactions with MCM1.
MCM1 binds to genes involved in the transition from the resting state to proliferative state in yeast and mammals
We noticed that a sequence motif used by higher cells to control genes in response to growth factors resembles the MCM 1 control element. Transcription of the human c-fos gene is responsive to serum, and is stimulated to high levels within 5 min after addition of serum or certain growth factors found in serum (Treisman 1985) . This effect is mediated by a DNA element with dyad symmetry found in the c-fos promoter, the SRE (Treisman 1987) . This sequence binds a protein, the SRF, which has been isolated from human cells (Prywes and Roeder 1987; Treisman 1987) .
We tested the mammalian c-fos variant of SRE, CCTAATATGG, for its ability to bind MCM1. The sequence of this element closely resembles the MCE. Figure 7A shows the results of a gel-retardation experiment demonstrating that an oligonucleotide corresponding to the human c-fos SRE is able to bind to MCM1 (1-188) (Fig. 7A, lane 2) . This SRE was able to form D N A -protein complexes with MCM 1 ( 1 -188) and gave rise to a multiple-banding pattern similar to that seen for the MCMl-binding sites derived from STE6 (Fig.  7A , lane 11) and STE2 (see Fig. 2 ). Slower migrating antib o d y -D N A -p r o t e i n complexes were formed when anti-MCM1 antiserum was added (Fig. 7A, lanes 3 and  12) but not with the addition of preimmune serum (Fig.  7A, lane 4) , which indicated that MCM1 (1-188) was responsible for binding to the labeled substrate in each case. We have also shown that addition of a polymer of the DSE14 sequence competes for the binding of MCM1 to its substrates (Fig. 7A, lanes 5 and 6) . Recently, Hayes et al. (1988) have observed a DNA-binding activity in yeast extract that binds to the m a m m a l i a n c-fos SRE.
A search for MCE sequences in front of known yeast genes revealed that similar sequences occur upstream of several genes, including CDC31 (Baum et al. 1986 ), a gene necessary for spindle pole body duplication, and CDC28 (Lorincz and Reed 1984) , a gene that encodes a protein kinase involved in the control of cell-cycle progression from G1 to S phase. The MCE found upstream of the CDC28 gene occurs at position -142 relative to the transcript start site, a plausible location for a UAS. A 26-mer oligonucleotide corresponding to the upstream region of CDC28 containing the MCE-like sequence was synthesized and tested for binding to MCMl-188. As shown in Figure 7A , MCM1 (1-188) also binds to the MCE upstream of CDC28, giving rise to multiple bands, and addition of anti-MCM1 antibody results in further retardation of the MCM1 ( 1 -1 8 8 ) -D N A complex (Fig.  7A, lanes 9) . Figure 7B shows the sequence of the consensus MCE as well as the related binding sequences from STE2 and STE6. The c-fos SRE sequence contains the CCTAAT motif, which is entirely conserved in the MCE sites of aand a-specific genes and shows strong binding to MCM1 (1-188).
The human c-fos SRE acts as a UAS in yeast
The binding of MCM1 to the h u m a n c-fos SRE prompted us to test whether the h u m a n c-fos SRE and other CCTAAT-containing elements can serve as UASs, and if so, whether this activity is mediated through the MCM1 protein. To do so we monitored the [3-galactosidase activity expressed from a STE2-1acZ fusion protein. The upstream regulatory sequence (URS) of the STE2 gene is contained within a HindIII fragment that can be removed and replaced with other DNA sequences (Smith 1986) . DNA sequences containing either DSE14 or the c-fos SRE were placed upstream of the TATA sequence of the STE2-1acZ gene fusion (Fig. 8A) .
The [3-galactosidase activity of the STE2-1acZ fusion gene bearing an intact upstream regulatory region (CD14) is 41 U/mg of protein in c~ cells and 1791 U/mg of protein in a cells (Fig. 8B) . This low activity in ot cells and high activity in a cells is expected for an a-specific gene whose transcription is regulated by the oL2 protein.
We show that the expression of STE2 can be modulated by MCM1. When a high-copy-number plasmid containing the MCM1 gene was introduced into these strains, we found that the increased MCM1 concentration enhanced the expression of the STE2-1acZ fusion protein in a cells approximately twofold, but had no ef- In contrast to the STE2 URS, which acts as a cell-typespecific UAS, DSE14 acts as a cell-type-nonspecific UAS, a result similar to that reported by Jarvis et al. (1988) . Only a modest stimulation in the UAS activity of DSE14 was observed with increased levels of MCM1 (Fig. 8B) , while carboxy-terminal disruptions of MCM1 result in a drastic decrease in activation by this sequence (R. Elble, unpubl.). The c-fos SRE exhibited no detectable UAS activity in wild-type strains of either mating type. However, overproduction of MCM1 stimulated expression at least sevenfold. Like DSE14, this element did not show cell-type specificity.
We used a competition assay (see Experimential procedures) to measure the relative binding affinities of DSEI4, STE2-o, MFe~d-o, and the c-fos SRE for MCM1 ( 1 -1 8 8 ) . The amount of cold competitor necessary to reduce by half the amount of bound c-fos SRE was determined using a gel-retardation assay. The relative binding affinities of MCM1 (1-188) for these sites are presented in Table 1 . The affinity of MCM1 for these elements in decreasing order is: DSE14 > STE2-o > MFotd-o > c-fos SRE. The relative UAS activity for these different sequences is STE2 > DSE14 > c-fos SRE. The higher affinity of MCM1 (1-188) for DSE~4 compared with the c-los SRE is consistent with the higher UAS activity observed for DSE~4 in vivo. However, the STE2-o-binding affinity cannot be compared directly with the UAS activity of STE2 because the HindIII fragment used in this construction is known to contain another MCMl-independent UAS (Smith 1986 ). We expected that the MCMl-dependent enhancement of the UAS activity should reflect the binding affinity: Sequences that have the highest affinity should be the least enhanced by MGM1 overproduction if the concentration of MCM1 is saturating for the high-affinity sites. This was, in fact, the case (Table 1 ).
These studies demonstrate that MCM1 has the property crucial to transcription factors that regulate a large number of genes. It can exert different effects on its target sites depending on its affinity to the target site and the factors that modulate its binding to these sites.
D i s c u s s i o n
Role of MCM1 in the expression of mating-type-specific genes
We have presented evidence that confirms the role of MCM1 as a transcriptional regulator by showing that MCM1 binds to the upstream-regulatory sites of a-and c~-specific genes. Moreover, MCM1 appears to bind cooperatively with ~1 to the UASs of MFRI and probably other oL-specific genes as well. In addition, we have shown that oligonucleotides containing the MCM1-binding site exhibit UAS activity in vivo, and that this activity is responsive to the level of MCM1.
The DNA-binding specificity of the MCM1 protein suggests that it is related to GRM and PRTF, two previously identified DNA-binding activities found in yeast extracts. The mutant phenotypes of rectal-1 suggest that MCM1 plays an important role in the regulation of mating-type-specific genes in ot cells by working in concert with the od protein. The mcml-1 mutation causes reduced transcription of a-specific genes (Passmore et al. 1988 ) and this mutation can be suppressed partially by the overproduction of the al protein (C. Christ, unpubl.). We have shown that MCM1 is able to bind to the UASs of a-specific genes without the help of the a 1 protein. Although MCM 1 expression is cell-type independent, the a-specific genes are not expressed in a-cells. We presume that the intracellular levels of MCM1 are not high enough to allow efficient binding to the a-specific UASs in the absence of its cofactor R1. Our previous results, which showed that overproduction of MCM1 can suppress partially the mating defect of a matal mutation (Passrnore et al. 1988) , are consistent with this interpretation. These properties suggest that MCM1 may encode PRTF (Bender and Sprague 1987; Jarvis et al. 1988) .
MCM1 seems to play only a limited role in the expression of a-specific genes in a cells. This is evident from the twofold reduced expression of STE2 in the mcml-1 mutant (Passmore et al. 1988) and from the weak UAS activity supplied by the MCMl-binding site within the a2 operator upstream of STE6 (Keleher et al. 1988) . Consistent with these observations, the in vitrobinding affinity of MCM1 for the MCE upstream of aspecific genes is very similar to its affinity for the MCEs of a-specific genes, which require the presence of R1 for efficient expression. The involvement of MCM1 in repression of a-specific genes is suggested by genetic evidence. Deletion mutations removing the carboxy-terminal region of MCM1, which encodes glutamine-rich tracts, result in the derepression of a-specific genes in R cells (R. Elble, unpubl.) . Substitution mutations of the MCMl-binding site within an R2 operator fail to repress a-specific transcription in a-cells (Keleher et al. 1988) . The derepression of a-specific genes in certain mcml mutants and the DNA-binding specificity of MCM1, suggest that MCM1 may encode GRM, the corepressor with ~2 of a-specific genes.
These genetic and biochemical properties of MCM1 are summarized in a model (Fig. 9 ) modified from Keleher et al. (1988) and Sauer et al. (1988) . In this model, MCM 1 (GRM/PRTF) plays an important role in the regulation of mating-type-specific genes in R cells by working in concert with the R1 and R2 proteins. The R1 protein is required in vivo for transcription of a-specific genes and it functions by enhancing MCMI(PRTF) binding to the a-specific UASs interacting specifically with ATTAGG on both strands of the MCE. Once bound, MCM1 can present its acidic domain to the transcription machinery and activate transcription. Moreover, MCMI{GRM) functions with R2 as a repressor of a-specific genes in a cells. GRM(MCM1) and a2 bind cooperatively (Keleher et al. 1988; Saner et al. 1988 ), suggesting that the proteins interact. We propose that a2 interacts with MCM1 such that it masks the acidic patch, rendering MCM1 incapable of activating transcription. In addition, this complex forms an effective block to transcription mediated by other UASs by some as yet unknown means (Keleher et al. 1988) .
MCM1 is an essential gene, and therefore must function beyond the capacity of a regulator of mating-typespecific gene expression. MCM1 may act as a more global transcriptional regulator that is required for the expression of a number of essential genes, one being the CDC28 gene. We have shown that MCM1 can interact with a DNA element located 142 bp upstream of the CDC28 transcription start site. CDC28 encodes a protein kinase involved in the regulation of the progression of the yeast cell cycle from G~ to S, perhaps being required for the initiation of DNA synthesis (Hereford and Hartwell 1974) .
The binding of MCM1 to DNA
We have shown that MCM1 (1-188) binds to a number of sequences related to the consensus dyad symmetry element CCTAATTAGG. The regulatory regions of both a-and a-specific genes contain MCEs that are bound by MCM1 (1-188) in vitro. Our binding data are summarized in Table 1 . We have constructed a series of symmetric double mutations within the MCE that change the sequence of both 'half-sites' in the internal AT-rich region. None of the mutant binding sites was an efficient competitor, which indicates that the sequence of the innermost six positions of the MCE is important for binding. A conserved sequence, CCTAAT, is found in all of the substrates we have examined that are recognized by MCM1 (1-188). Deviations from DSE10 occurring at every position other than CCTAAT are tolerated. One binding substrate, the CCTAATT polymer, which contains only one of the half-sites, was of particular interest: It served as a competitor for the binding of MCM1 to the symmetric MCE. Nicking interference experiments indicate that MCM1 interacts with each AT-TAGG of the MCE on both strands. Furthermore, methylation of G9 or Glo on either strand abolishes binding of MCM1. Together these results suggest that MCM1 binds as a dimer to symmetric sites within the MCE. The relative affinities of MCM1 (1-188)for some of the binding sites have been determined. We found that those sequences that were the best binding substrates in vitro were enhanced the least by increasing the levels of MCM1 in vivo. This inverse correlation suggests that the intracellular concentration of MCM1 is such that binding sites of different affinities can use MCM1 to drive transcription at different levels. This is a property expected of a transcription factor that regulates multiple genes.
Multiple bands corresponding to MCM1-DNA complexes are seen in gel-retardation assays, even when oligonucleotides containing a single 10-bp-binding site were used as substrate. We suspect that the multiple bands arise from homo-and heterodimers of MCM1 (1-188) and its proteolytic fragment binding to a common substrate. Two lines of evidence suggest that this is the cause of the multiple bands: (1) MCM1 purified from a SDS-polyacrylamide gel and then renatured gives only one shifted complex and (2) the various shifted complexes have the same DNase I footprints.
Cooperative binding of MCM1 with od
The binding of MCM1 to R-specific UASs can be potentiated by the regulatory protein MATR1. The R1 protein is believed to act by binding to a conserved sequence motif found in s-specific UASs. This motif is located immediately adjacent to the MCEs of the oL-specific genes. We have shown that addition of R1 enhances the binding of MCM1 to MFR1-UAS2. In addition, the region protected from DNase I digestion is extended in the presence of R1 tO include the conserved motif. These results suggest that MCM1 and oL1 bind cooperatively to the UASs of a-specific genes. It is possible that the e~l protein enhances the formation of the MCM1-DNA complex solely by interacting with MCM1, rather than by binding directly to the a-specific UAS. Our inability to detect R1 enhancement of MCM1 binding to a-specific genes makes this interpretation unlikely. We have been unable to detect any change in the mobility of the MCM1-DNA complex in the presence of the R1 protein. Perhaps the R1/MCM1-DNA complex was not stable under the conditions used in the gel-retardation assay; alternatively, it is possible that the mobility of an al/MCM1-DNA complex is indistinguishable from that of an MCM1-DNA complex.
Relationship to other transcription factors
MCM1 is a member of a family of related proteins that may all function as transcription factors. MCM1 bears Cold Spring Harbor Laboratory Press on November 6, 2017 -Published by genesdev.cshlp.org Downloaded from Figure 9 . Summary of the properties and function of MCM1 in the regulation of mating-type-specific genes in c~ cells based on a model modified from Keleher et al. (1988) and Sauer et al. (1988) . striking homology to the yeast protein ARG80, a transcriptional or post-transcriptional (Messenguy and Dubois 1983) regulator of the arginine metabolic pathway. Within a region of 79 amino acids there is 70% identity between these two proteins (Passmore et al. 1988) . Both MCM1 and ARG80 may function as components of multisubunit complexes. ~1 enhances the binding of MCM1 to ~-specific UASs and both are needed for expression of ~-specific genes, whereas MCM1 and e~2 interact to repress the expression of aspecific genes. Genetic evidence suggests that ARG80, ARG81, and ARG82 interact to promote the expression of catabolic genes of the arginine pathway and to repress arginine anabolic genes (Bechet et al. 1970 ). Although we believe that MCM1 encodes GRM and PRTF based on their DNA-binding specificities and their postulated role in the control of mating-type-specific expression, we cannot rule out the possibility that they are members of a family of related transcription factors. There are precedents for distinct transcription factors that have similar DNA-binding specificities and immuno-crossreactivities (Santoro et al. 1988) .
A sequence motif used by higher cells to control genes responsive to growth factors resembles the MCM1-binding site. The sequence element SRE is acted on by the transcription factor SRF. We have shown that the MCM1 protein will bind to the SRE. Furthermore, the human c-los SRE can act as a UAS in the expression of genes in yeast when the MCM1 protein is present at high levels in the cell. A comparison of the protein sequences of MCM1 and human SRF shows that they are highly homologous to each other in the DNA-binding/ dimerization domain, a domain that also is conserved between the MCM1 and ARG80 proteins (Norman et al. 1988; Passmore et al. 1988) . Thus, the transcription factors MCM1 and SRF, as well as their DNA recognition sequences, have been conserved over large evolutionary distances.
Possible role in DNA replication
MCM1 is a versatile transcription factor that can act as a transcriptional activator when presented with ~1 and a transcriptional repressor when presented with ~2. It is possible that if presented with the appropriate factor(s), it may serve yet another important role in the cell--to regulate DNA replication initiation either as a transcriptional regulator of genes involved in DNA replication or as a DNA replication initiator. The mcml-1 mutation was isolated originally as a mutation that affected the function of specific ARSs on minichromosomes. Inspection of nucleotide sequences of ARSs reveals that there are multiple MCE-like elements in certain ARSs (V. Chang, unpubl.) . Many examples of site-specific DNA-binding proteins playing dual roles in transcriptional activation and replication initiation in eukaryotes have been described (Dean et al. 1987; Jones et al. 1987; Mecas and Studgen 1987; Pruijn et al. 1987; Stenlund et al. 1987; O'Neill and Kelly 1988) . A recent report by Santoro et al. (1988) convincingly showed that a family of CCAAT-box binding proteins serves both as promoter-selective transcription activators and as initiation factors for DNA replication in mammalian in vitro systems. It is tempting to speculate that in yeast, the transcription of mating-type-specific genes and the initiation of DNA replication may be regulated by MCM1 via similar control elements. This control mechanism may be conserved in evolutionarily diverse organisms to allow the transcription of growth-related genes and the initiation of DNA replication to coordinately respond to the same growth stimuli.
E x p e r i m e n t a l procedures
Overproduction and purification of MCM1 protein
The plasmid pETMCM1 (1-188) was constructed to overexpress a phage T7 6-10-MCM1 fusion protein. A DNA fragment, which extends from a BamHI linker 14 bp upstream of the start of translation to the EcoRI site within the coding sequence of the MCM1 gene, was placed into the expression plasmid pET3b, which had been cut with these same two enzymes (Rosenberg et al. 1987) . pETMCM 1 (1-188) was transformed into the strain BL21(DE3), which carries an integrated, inducible copy of the phage T7 RNA polymerase. This strain also contains a plasmid (pLysE) that constitutively expresses a low level of the phage T7 lysozyme, which inhibits the basal T7 RNA polymerase activity. The expression of the MCM1 fusion protein was induced by the addition of isopropyl-[3-D-thiogalactopyranoside to 1 mlvi to a rapidly growing culture at OD66 o = 0.4. After 2 hr, the culture was harvested, washed, and then lysed by repeated freezethaw cycles in buffer LB150 containing 3% streptomycin sulfate. LB150 is lysis buffer (LB) containing 150 mM NaC1. LB buffer is 50 mlvi Tris-HC1 (pH 7.9), 10 mM BME, 1 mM MgC12, and 0.1 ~ EDTA. This lysate was cleared by a 1-hr 30,000g spin at 4~ and then loaded onto a BioRex 70 column equilibrated with LB150. The MCM1 protein was eluted from this column with a linear NaC1 gradient in LB and eluted at -580 mM NaC1. The MGM1 protein was assayed during the purification both for its DNA-binding activity, and by immunoblot analysis of the various fractions. The peaks of binding activity and immuno-cross-reactive material were coincident. The MCM1 protein obtained from the elution peak is -30% MCM1, as judged by Coomassie brilliant blue staining of the peak fractions when separated by SDS-PAGE.
Antisera preparation and immunological techniques
The plasmid pURMCM1 was constructed to overexpress a LacZ-MCM1 fusion protein. The 575-bp BamHI-EcoRI fragment from BH-14 (Passmore et al. 1988 ) was inserted into the plasmid pUR278 (Riither and Miiller-Hill 1983) , creating a translational fusion of the lacZ and MCM1 genes. This gene fusion encodes a 1219-amino-acid protein containing the amino-terminal 188 amino acids of the MCM1 protein. An E. coli strain bearing this plasmid was induced to express the LacZ-MCM1 fusion protein by the addition of IPTG. Total protein from this strain was fractionated by SDS-PAGE, as described by Laemmli (1970) , using an 8% resolving gel. The LacZ-MCM1 protein was electroeluted from the gel, mixed with Freund's complete adjuvant, and used to immunize New Zealand White rabbits. The rabbits were boosted three times with antigen in Freund's incomplete adjuvant and the immune sera was harvested, 9 weeks after the initial immunization.
The immunoblots were performed as follows: proteins were transferred from SDS-PAGE onto nitrocellulose and probed using rabbit anti-MCM1 antisera, essentially as described by Towbin (1979) , except that 5% nonfat powdered milk was used as a blocking agent. Bound antibody was detected using goat anti-rabbit IgG conjugated to alkaline phosphatase (Bio-Rad), which was visualized as described by the supplier.
Footprint reactions
The DNAs used in the footprinting experiments of the regulatory region of MFal were the plasmid pKSMFal and the oligonucleotide MFcdp60. pKSMFal was constructed by inserting the SspI-XhoII DNA fragment containing the MFal regulatory elements from the plasmid pHK2 (provided by I. Herskowitz) into the polylinker of the plasmid BluescriptKS (+) which had been cut with Sinai and BamHI. pKSMFal was 3'-end-labeled by first cutting with the enzyme HindIII, then filling in the ends with T4 DNA polymerase. This DNA was then recut with the enzyme BamHI and the fragment was isolated from a 6% DNA-binding properties of MCM1 polyacrylamide gel. MF~ lp60 was 3'-end-labeled on the coding strand using the Klenow form of DNA polymerase I and radioactive dATP, and the noncoding strand was labeled similarly using radioactive dCTP. The DNase I cleavage was carried out in two steps. First, labeled DNA and MCM1 protein were mixed and allowed to bind at room temperature for 10 rain in BB [150 mM NaC1, 20 mM Tris-HC1 (pH 8.0), 1 ~ MgC12, 5 mM CaC12, 0.1 mM EDTA, I0% glycerol, 0.1 ~g/~l BSA, 1 ng/}zl poly[d(I-C)]. Then poly[d(I-C)l was added to 50 nghzl (20-~1 reaction) followed by addition of DNase I. Except as noted above, solution cleavage conditions and further processing were essentially as described by Wiederrecht et al. (1987) . The DNase I digestion patterns of the different forms seen in the gel-retardation assay were examined by first carrying out the footprinting reaction as described above using end-labeled MF~lp60 fol~ lowed by a preparative retardation gel. The bands of interest were excised, diffusion-eluted into TE, and concentrated by butanol extraction. The pKSMF~I cleavage products were then separated on an 8% sequencing gel using sequencing reactions for size standards. MFalp60 cleavage products were separated on an 13% sequencing gel.
Nicking and DMS interference assays
To identify the strand and sequence positions important for MCM1 binding, DNase I nicking was used as the basis for a binding-interference assay. DNA from the promoter of MFal was nicked using DNase I, this collection of nicked DNA was then allowed to bind under conditions of protein excess and the bound and nonbound forms were fractionated using the gel-retardation system, followed by separation of the denatured DNA on a sequencing gel. The oligonucleotide MF~lp60 was used for all the nicking interference assays; this DNA was 3'-end-labeled using the Klenow fragment of DNA polymerase L The DNase I digestion conditions are essentially as described above (see Footprint reactions). To identify base positions that are essential for binding, all of these assays were carried out in the presence of excess protein, such that greater than 95% of the input DNA was shifted in the absence of DNase ! treatment. The bound and nonbound classes were fractionated using the gel system described for the PAGE-retardation experiments. The bound and nonbound classes of nicked DNA were identified by autoradiography; a gel slice containing these DNAs was excised and crushed and the DNA was eluted into TE by an overnight incubation at 4~ The eluted DNA was concentrated by extraction with N-butanol, dried, denatured by heating in formamide loading dye, and applied directly to a sequencing gel. DNA was methylated partially with dimethylsulfate, and precipitated from ethanol several times. The methylated DNA was used for an interference assay as described above. After isolation, the bound and nonbound forms were cleaved using the G greater than A method, as described by Siebenlist and Gilbert {1980).
PAGE retardation experiments
Unless otherwise noted, all substrates for gel-retardation experiments were labeled by replacement synthesis using T4 DNA polymerase, essentially as described by O'Farrell (1981) . The labeled DNA was purified by PAGE before use. Oligonucleotides were labeled either by T4 kinase or by filling in ends with the Klenow fragment of polymerase. Approximately 2 ng (except as noted in the figures) of the MCM1 protein was mixed in 20 ~1 BB followed by addition of probe (-1 fM). The binding was allowed to occur at room temperature for 10 min. The DNA-Cold Spring Harbor Laboratory Press on November 6, 2017 -Published by genesdev.cshlp.org Downloaded from protein complexes were resolved on a 15 cm, 6% polyacrylamide gel (40: 1, acrylamide/bis) buffered with TB [50 mM Tris-borate (pH 8.7), 1.0 mM EDTA] at 150 V for 1-4 hr as appropriate for the DNA fragment of interest. The free DNA and DNA-protein complexes were then visualized by autoradiography.
Quantitative competition assays
Polymers of the binding site mutations were used as competitors. Approximately 1 fM of probe was present in each reaction, and the competitor was added to the reaction prior to the addition of the probe. Quantitative competition assays were performed using the c-los MCE as the probe in a gel-retardation assay under conditions that -30% of the probe formed DNAprotein complexes. Various amounts of cold competitor DNAs were added before addition of MCMl-188 protein. Autoradiograms were scanned using a BioRad model 620 video densitometer. The amount of cold competitor necessary to reduce the amount of shifted probe by half (S1/2) was calculated. Relative affinities were calculated as the ratio of the S% of DSE~4 to the S1/2 of the particular oligonucleotide.
Oligonucleotides
O1igonucleotides were synthesized by the Cornel1 oligonucleutide synthesis facility, except for STE6-o which was a gift from C. Keleher. Their sequences are shown below or in the appropriate figures. 
fl-Galactosidase activity assays
B-Galactosidase activity assays were carried out as described by Guarente (1983) , except that a washing step was introduced to remove the red color resulting from the ade2 mutation in the a strain. Cells were permeabilized in chloroform/SDS, pelleted by centrifugation, and resuspended in Z-buffer (Guarente 1983) containing chloroform/SDS and o-nitrophenyl-B-D-galactoside. Units of B-galactosidase activity were calculated as: (OD42 o x 1000)/(t x m); where t is reaction time in minutes and m is milligrams of cell protein. Protein content was determined using the Bradford protein assay after breaking the cells with glass beads.
